Incyte Corporation (INCY) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Incyte Corporation (INCY)
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
incyte.com/ir/investor-overview.aspx
Company Research
Source: Seeking Alpha
William Meury - CEO, President & Director Conference Call Participants Marc Frahm - TD Cowen, Research Division Presentation Marc Frahm TD Cowen, Research Division All right. Welcome back to the 46th Annual TD Cowen Healthcare Conference. Really happy to have the next session here with -- I'm Marc Frahm from the biotech team here at TD Cowen, and we're really happy to have the next session, Incyte with Bill Meury, the CEO, to join. Question-and-Answer Session Marc Frahm TD Cowen, Research Division Maybe just start off with, Bill, do you want to just give a kind of high-level kind of status update of the company? What do you think the kind of key value creation events for investors will be over the next 12 to 24 months? William Meury CEO, President & Director Yes, sure. Thanks, Marc. I think about the business in three parts. Part one is we're focused on our core business ex Jakafi, which in 2025 finished at about $1.2 billion. We estimate by the end of '26,
Show less
Read more
Impact Snapshot
Event Time:
INCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
News
- Incyte (INCY) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c+)" to "buy (b-)".MarketBeat
- Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata [Yahoo! Finance]Yahoo! Finance
- Does Incyte's 2025 Beat And 2026 Guidance Shift The Bull Case For INCY? [Yahoo! Finance]Yahoo! Finance
- Incyte Corp. (INCY) Reports Q4 2025 Revenue Growth of 28% to $1.51B Driven by Jakafi and Opzelura Sales [Yahoo! Finance]Yahoo! Finance
- Where is Incyte Corporation (INCY) Headed According to Analysts? [Yahoo! Finance]Yahoo! Finance
INCY
Earnings
- 2/10/26 - Beat
INCY
Sec Filings
- 2/23/26 - Form 4
- 2/19/26 - Form 144
- 2/10/26 - Form SCHEDULE
- INCY's page on the SEC website